Results 31 to 40 of about 4,961,010 (265)
Mineralocorticoid receptor signalling in primary aldosteronism.
Journal of Endocrinology, 2023 Primary Aldosteronism, or Conn Syndrome, is the most common endocrine cause of hypertension. It is associated with a higher risk of cardiovascular, metabolic and renal diseases, as well as a lower quality of life than for hypertension due to other causes.
Jun Yang +3 more
semanticscholar +1 more source
Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection.
American Journal of Kidney Diseases, 2023 A clinical condition may be missed due to its higher-than-recognized prevalence or inadequate diagnostic screening. Primary aldosteronism suffers from both of these factors and thus, is woefully underdiagnosed as a cause of hypertension and end-organ ...
Mario Funes Hernandez, Vivek Bhalla
semanticscholar +1 more source
Screening for primary aldosteronism on and off interfering medications
Endocrine, 2023 Objective To determine whether antihypertensives will affect diagnostic accuracy of the aldosterone-to-renin ratio (ARR) to an extent that is clinically relevant. Methods Confirmatory tests were used to confirm or exclude PA diagnosis.
Xiaoyu Li +16 more
semanticscholar +1 more source
Primary Aldosteronism: State-of-the-Art Review.
American Journal of Hypertension, 2022 We are witnessing a revolution in our understanding of primary aldosteronism. In the past two decades, we have learned that primary aldosteronism is a highly prevalent syndrome that is largely attributable to pathogenic somatic mutations, that ...
A. Vaidya +4 more
semanticscholar +1 more source
Detecting primary aldosteronism in Australian primary care: a prospective study
Medical Journal of Australia, 2022 To assess the identification of primary aldosteronism (PA) in newly diagnosed, treatment‐naïve patients with hypertension by screening in primary care.
Renata Libianto +8 more
semanticscholar +1 more source
Kidney International, 1984 We retrospectively reviewed the clinical features, methods of diagnosis and localization, and results of treatment in 105 patients with primary aldosteronism seen between 1969 and 1981. Coincident with the use of computed tomography (CT), 131I-6-beta-iodomethyl norcholesterol scans (NP-59), and postural response studies, the study group was temporally ...
C S, Grant +3 more
+8 more sources
BMC Endocrine Disorders, 2021 Background Various adrenal disorders including primary aldosteronism and Cushing’s syndrome lead to the cause of hypertension. Although primary aldosteronism is sometimes complicated with preclinical Cushing’s syndrome, concurrence of overt Cushing’s ...
Yoshiro Fushimi +8 more
doaj +1 more source
Xiehe Yixue Zazhi, 2022 Subtype classification of primary aldosteronism is important but challenging. Increasing evidence has shown that 68Ga-Pentixafor PET/CT imaging which targets CXCR4 is beneficial to the subtype classification of primary aldosteronism.
Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group +2 more
doaj +1 more source
HYPERTENSION, 2021 Supplemental Digital Content is available in the text. Primary aldosteronism is a common, yet highly underdiagnosed, cause of hypertension that leads to disproportionately high rates of cardiovascular disease. Hypertension plus hypokalemia is a guideline-
G. Hundemer +8 more
semanticscholar +1 more source
Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight
International Journal of Molecular Sciences, 2022 Primary aldosteronism (PA) is a pathological condition characterized by an excessive aldosterone secretion; once thought to be rare, PA is now recognized as the most common cause of secondary hypertension.
F. Bioletto +8 more
semanticscholar +1 more source